Tanja Trarbach

3.8k total citations
93 papers, 2.6k citations indexed

About

Tanja Trarbach is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Tanja Trarbach has authored 93 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Oncology, 49 papers in Pulmonary and Respiratory Medicine and 30 papers in Surgery. Recurrent topics in Tanja Trarbach's work include Colorectal Cancer Treatments and Studies (53 papers), Gastric Cancer Management and Outcomes (30 papers) and Cancer Treatment and Pharmacology (28 papers). Tanja Trarbach is often cited by papers focused on Colorectal Cancer Treatments and Studies (53 papers), Gastric Cancer Management and Outcomes (30 papers) and Cancer Treatment and Pharmacology (28 papers). Tanja Trarbach collaborates with scholars based in Germany, United States and United Kingdom. Tanja Trarbach's co-authors include Dirk Laurent, U. Vanhoefer, Florian Lordick, Markus Moehler, N. Schleucher, Hauke Lang, Stephan Kanzler, Gunnar Folprecht, C.-H. Köhne and Andreas Paul and has published in prestigious journals such as Journal of Clinical Oncology, Oncogene and Radiology.

In The Last Decade

Tanja Trarbach

91 papers receiving 2.6k citations

Peers

Countries citing papers authored by Tanja Trarbach

Since Specialization

Citations

This map shows the geographic impact of Tanja Trarbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tanja Trarbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tanja Trarbach more than expected).

Fields of papers citing papers by Tanja Trarbach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tanja Trarbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tanja Trarbach. The network helps show where Tanja Trarbach may publish in the future.

Co-authorship network of co-authors of Tanja Trarbach

This figure shows the co-authorship network connecting the top 25 collaborators of Tanja Trarbach. A scholar is included among the top collaborators of Tanja Trarbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tanja Trarbach. Tanja Trarbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	438P Interim safety analysis of the phase IIb study of ramucirumab in combination with TAS102 vs. TAS102 monotherapy in metastatic colorectal cancer: The RAMTAS trial of the German AIO 2020 ·Annals of Oncology ·Stefan Kasper, Ralf‐Dieter Hofheinz, Sebastian Stintzing, (unknown), M. Sinn, Tobias Dechow, Thomas J. Ettrich, Verena Keitel, Ullrich Graeven, Ludwig Fischer von Weikersthal, (unknown), (unknown), Alexander Stein, Tanja Trarbach, (unknown), Claudia Pauligk, (unknown), Jens T. Siveke, S-E. Al-Batran, Martin Schüler	1
2	A randomized phase II study of paclitaxel alone versus paclitaxel plus sorafenib in second- and third-line treatment of patients with HER2-negative metastatic breast cancer (PASO) 2017 ·BMC Cancer ·Thomas Decker, Friedrich Overkamp, Siegfried Rösel, Arnd Nusch, Thomas Göhler, (unknown), (unknown), Tanja Trarbach	22
3	Quality of life assessment in patients with metastatic colorectal cancer receiving maintenance therapy after first-line induction treatment: a preplanned analysis of the phase III AIO KRK 0207 trial 2016 ·Annals of Oncology ·Julia Quidde, Susanna Hegewisch‐Becker, Ullrich Graeven, Christian Lerchenmüller, B. Killing, Reinhard Depenbusch, Claus-Christoph Steffens, Thoralf Lange, Georg Dietrich, Jan Stoehlmacher, (unknown), (unknown), Tanja Trarbach, Norbert Marschner, Hans‐Joachim Schmoll, Axel Hinke, Salah‐Eddin Al‐Batran, Dirk Arnold	18
4	Quality of life in patients with metastatic colorectal cancer receiving maintenance therapy after first-line inductive treatment: A quality of life sub-analysis of the AIO KRK 0207 phase III trial 2016 ·Annals of Oncology ·Julia Quidde, (unknown), Ullrich Graeven, C. Lerchenmueller, B. Killing, Reinhard Depenbusch, Claus-Christoph Steffens, Thoralf Lange, Georg Dietrich, Jan Stoehlmacher, (unknown), Andrea Tannapfel, Tanja Trarbach, Norbert Marschner, Hans‐Joachim Schmoll, Axel Hinke, S-E. Al-Batran, Dirk Arnold	0
5	Cetuximab biweekly (q2w) plus mFOLFOX6 as 1st line therapy in patients (pts) with KRAS wild-type (wt) (exon 2) metastatic colorectal cancer (mCRC) – Primary endpoint and subgroup analysis of the CEBIFOX trial 2016 ·Annals of Oncology ·Stefan Kasper, Jens Meiler, H. Knipp, Thomas Höhler, Peter Reimer, (unknown), W. Berger, (unknown), Saskia Ting, P. M. Markus, A. Paul, Alexander Dechêne, Brigitte Schumacher, (unknown), Karl Worm, Kurt Werner Schmid, Tobias Herold, Martin Schüler, Tanja Trarbach	1
6	Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial 2015 ·The Lancet Oncology ·Susanna Hegewisch‐Becker, Ullrich Graeven, Christian Lerchenmüller, B. Killing, Reinhard Depenbusch, Claus-Christoph Steffens, Salah‐Eddin Al‐Batran, Thoralf Lange, Georg Dietrich, Jan Stoehlmacher, Andrea Tannapfel, Anke Reinacher‐Schick, Julia Quidde, Tanja Trarbach, Axel Hinke, Hans‐Joachim Schmoll, Dirk Arnold	176
7	An open-label, multicentre biomarker-oriented AIO phase II trial of sunitinib for patients with chemo-refractory advanced gastric cancer 2011 ·European Journal of Cancer ·Markus Moehler, Annett Mueller, J.T. Hartmann, M. Ebert, Salah‐Eddin Al‐Batran, Peter Reimer, Martin R. Weihrauch, Florian Lordick, Tanja Trarbach, Stefan Biesterfeld, Maria Kabisch, Daniel Wachtlin, Peter R. Galle	73
8	Cancer Patients and the Internet: A Survey of the ‘Quality of Life’ Working Groups of the Arbeitsgemeinschaft für Internistische Onkologie and the Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie 2011 ·Onkologie ·Deniz Gencer, (unknown), (unknown), Salah‐Eddin Al‐Batran, Michael Ståhl, (unknown), Matthias Hipp, (unknown), Nicole Prasnikar, Tanja Trarbach, Christoph Stoll, Michael van Kampen, Andreas Hochhaus, Sylvie Lorenzen, Ralf‐Dieter Hofheinz	7
9	Safety distance in the resection of colorectal lung metastases: A prospective evaluation of satellite tumor cells with immunohistochemistry 2010 ·Journal of Thoracic and Cardiovascular Surgery ·Stefan Welter, Dirk Theegarten, Tanja Trarbach, (unknown), Georgios Stamatis, Martin Tötsch	34
10	Interdisciplinary management of EGFR-inhibitor-induced skin reactions: a German expert opinion 2010 ·Annals of Oncology ·Karin Potthoff, Ralf‐Dieter Hofheinz, Jessica C. Hassel, Matthias Volkenandt, Florian Lordick, J.T. Hartmann, Meinolf Karthaus, Hanno Riess, Hans‐Peter Lipp, Axel Hauschild, Tanja Trarbach, Andreas Wollenberg	86
11	Tumor markers as a diagnostic key for hilar Cholangiocarcinoma 2010 ·European journal of medical research ·(unknown), Sonia Radünz, Matthias Heuer, Sabine Hertel, Henning Reis, (unknown), Spiridon Vernadakis, Tanja Trarbach, A. Paul, G Kaiser	54
12	Spezielle Therapiesituationen beim metastasierten kolorektalen Karzinom 2010 ·Onkologie ·Dirk Arnold, Hans‐Joachim Schmoll, Hauke Lang, Wolfram Trudo Knoefel, Karsten Ridwelski, Tanja Trarbach, Ludger Staib, Thomas Kirchner, Michael Geißler, Thomas Seufferlein, Holger Amthauer, Hanno Riess, Hans J. Schlitt, Pompiliu Piso	5
13	Cetuximab with irinotecan/NA-FA/5-FU as first-line treatment in advanced gastric cancer: Preliminary results of a non-randomised multi-centre AIO phase II study 2008 ·mediaTUM (Technical University of Munich) ·Markus Moehler, Tanja Trarbach, T Seufferlein, S. Kubicka, Florian Lordick, Michael Geißler, S Daum, Jochen Wilke, Thomas Höhler, Stephan Kanzler, Peter R. Galle	8
14	Adjuvante Therapie des Kolonkarzinoms 2008 ·Onkologie ·Tanja Trarbach, Stefan Kubicka, Ulrich Hacker, Karsten Ridwelski, Anke Reinacher‐Schick	4
15	Die Therapie des Rektumkarzinoms 2007 ·Oncology Research and Treatment ·Rolf Sauer, Andrea Tannapfel, Claus Rödel, A. H. Hölscher, Rainer Fietkau, U. Vanhoefer, Tanja Trarbach	2
16	A phase IB, open-label dose-escalating study of the oral angiogenesis inhibitor PTK787/ZK 222584 (PTK/ZK), in combination with FOLFOX4 chemotherapy in patients with advanced colorectal cancer 2007 ·Annals of Oncology ·Anne Thomas, Tanja Trarbach, (unknown), Dirk Laurent, Andrew Henry, (unknown), Jim J. Wang, Eric Masson, W P Steward, U. Vanhoefer, Bertram Wiedenmann	40
17	Doxorubicin enhances TRAIL-induced cell death via ceramide-enriched membrane platforms 2007 ·APOPTOSIS ·Claudia A. Dumitru, Alexander Carpinteiro, Tanja Trarbach, Ulrich R. Hengge, Erich Gulbins	53
18	A meta-analysis of two randomized, double-blind, placebo-controlled, phase III studies in patients (PTS) with metastatic colorectal cancer (MCRC) receiving FOLFOX4 and PTK/ZK to determine clinical benefit on progression-free survival (PFS) in high LDH PTS 2006 ·Annals of Oncology ·Tanja Trarbach, Pierre Major, Heinz‐Josef Lenz, DJ Kerr, Kelly Pendergrass, Jean‐Yves Douillard, (unknown), Amanda Littlewood‐Evans, Laurent Dembélé, Christian Jacques, Eric Van Cutsem	2
19	Adjuvant chemoradiation using 5-fluorouracil/folinic acid/cisplatin with or without paclitaxel and radiation in patients with completely resected high-risk gastric cancer: two cooperative phase II studies of the AIO/ARO/ACO 2005 ·Annals of Oncology ·Christian Kollmannsberger, Wilfried Budach, M. Stahl, N. Schleucher, Thomas Hehr, H. Wilke, Jan Schleicher, U. Vanhoefer, E. C. Jehle, Karin Oechsle, Tanja Trarbach, (unknown), Lothar Kanz, J.T. Hartmann, Carsten Bokemeyer	31
20	Etoposide toxicity on human neuroblastoma cells in vitro is enhanced by preceeding hyperthermia 2001 ·Medical and Pediatric Oncology ·(unknown), (unknown), Tanja Trarbach, Bernhard Kremens	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact